NEW YORK, Oct. 16, 2017 -- ITG (NYSE:ITG), a leading independent broker and financial technology provider, plans to announce third quarter 2017 financial results on Wednesday, November 1, 2017, in a press release that will be issued before the opening of the U.S. market. The press release will also be available on the firm's website at investor.itg.com.
A conference call to discuss the firm's results will be held at 8:00 am ET on November 1, 2017. Those wishing to listen to the call should dial 1-844-881-0134 (1-412-317-6722 outside the U.S.) at least 15 minutes prior to the start of the call to ensure connection. The webcast and accompanying slideshow presentation will be available on ITG’s website at investor.itg.com. For those unable to listen to the live broadcast of the call, a replay will be available for one week by dialing 1-877-344-7529 (1-412-317-0088 outside the U.S.) and entering replay number 10112617. The replay will be available starting approximately one hour after the completion of the conference call.
About ITG
Investment Technology Group (NYSE:ITG) is a global financial technology company that helps leading brokers and asset managers improve returns for investors around the world. We empower traders to reduce the end-to-end cost of implementing investments via technology-enabled liquidity, execution, analytics and workflow solutions. ITG has offices in Asia Pacific, Europe and North America and offers execution services in more than 50 countries. Please visit www.itg.com for more information.
ITG Media/Investor Contact:
J.T. Farley
1-212-444-6259
[email protected]


Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 



